MDMA – A New Vision for Mental Health

Australia legalises psychedelics for mental health

Author: Editorial 3rd July 2023 0 Comments

Tiffany Wertheimer reports for the BBC: “Australia has become the first country in the world to legalise the use of psychedelics to treat some mental health conditions. Approved psychiatrists can now prescribe MDMA to those suffering post-traumatic stress disorder and magic…
Read more

collaborative practice

Australia, BBC, depression, magic mushrooms, MDMA, New Approaches, psilocybin, Psychedelic-assisted therapy, PTSD, Therapeutic Goods Administration, Tiffany Wertheimer

Psychedelics: The revolutionary drugs that could change your life – a guide from the expert

Author: Editorial 31st May 2023 0 Comments

This book has been written by Prof. David Nutt. The publishers say: “We are on the cusp of a major revolution in psychiatric medicine and neuroscience. After fifty years of prohibition, criminalisation and fear, science is finally showing us that psychedelics…
Read more

collaborative practice

ayahuasca, books, David Nutt, depression, Ketamine, LSD, magic mushrooms, MDMA, Neuropsychopharmacology, neuroscience, OCD, psilocybin, psychedelic drugs, PTSD

My Mind Medicine Australia Psychedelic Lecture Tour

Author: Editorial 8th March 2023 0 Comments

This article by Prof. David Nutt has been published by Drug Science. It begins: “I have just come back from a 3-week lecture tour of South-Eastern Australia supporting the cause of the charity Mind Medicine Australia (MMA) They have been raising money for psychedelic…
Read more

collaborative practice

Australia, David Nutt, Drug Science, MDMA, Mind Medicine Australia, psilocybin, Psychedelic-assisted therapy, Randomised Control Trials (RCTs), Real World Evidence, Research

Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses

Author: Editorial 6th February 2023 0 Comments

“… the decision will make Australia the first country in the world to officially recognise MDMA and psilocybin as medicines” This report (from Tory Shepherd for The Guardian) begins: “After decades of ‘demonisation’, psychiatrists will be able to prescribe MDMA and…
Read more

collaborative practice

Australia, David Caldicott, depression, MDMA, New Approaches, Post-Traumatic-Stress-Disorder, psilocybin, PTSD, The Guardian, Therapeutic Goods Administration, Tory Shepherd

The Top 10 Psychedelic Science Studies Of 2022

Author: Editorial 19th January 2023 0 Comments

This article by Zeus Tipado has been published by HealingMaps. It begins: “Before you can assemble a list of the top ten greatest psychedelic science studies of 2022, you must first read every psychedelic study of 2022. I cannot stress enough…
Read more

collaborative practice

HealingMaps, inflammation, Ketamine, lysergic acid diethylamide (LSD), MDMA, music therapy, Nature Relatedness, neuroscience, psilocybin, Psychedelic Drug Trial, Research, stress, Zeus Tipado

MDMA could help trauma survivors face painful memories

Author: Editorial 19th May 2021 0 Comments

Rachel Schraer reports for the BBC: “MDMA – most commonly known as a party drug – could be more effective than therapy alone at treating post-traumatic stress disorder (PTSD). The results of a keenly-awaited trial suggest two-thirds of people no longer qualified for a PTSD…
Read more

emotion-focused care

BBC, ecstasy, MDMA, Multidisciplinary Association for Psychedelic Studies, New Approaches, Post-Traumatic-Stress-Disorder, PTSD, Rachel Schraer, Research, trauma

Taking MDMA could help to treat alcoholism, study suggests

Author: Editorial 1st March 2021 0 Comments

Chiara Giordano reports for The Independent: “Taking MDMA could help treat alcohol addiction , according to a new study. During an eight-week trial in Bristol, 14 people with alcohol problems were given a controlled amount of the party drug, also known as ecstasy , during…
Read more

collaborative practice

alcohol dependence, alcoholism, Ben Sessa, Chiara Giordano, ecstasy, Imperial College London, Journal of Psychopharmacology, MDMA, Research, The Independent

How will psychiatrists administer psychedelic treatments?

Author: Editorial 11th February 2021 0 Comments

This article has been written (within an American context) by Derek Beres and published on the Big Think website. It begins: “Psychedelic therapy is imminent. Within six years, the market for this new wave of therapeutics is predicted to reach nearly $7 billion . With advocates and…
Read more

collaborative practice

audio, ayahuasca, Big Think, Derek Beres, ibogaine, LSD, MDMA, Multidisciplinary Association for Psychedelic Studies, psilocybin, psychedelic drugs, psychiatry, Rick Doblin

The case for funding psychedelics to treat mental health

Author: Editorial 22nd October 2020 0 Comments

“Scientists are developing psilocybin, the active ingredient in magic mushrooms, into a treatment for depression.” Reporting for Vox, Sigal Samuel writes : “… drugs like traditional antidepressants are, at best, only a partial solution . While their effectiveness has been hotly contested over the past…
Read more

collaborative practice

anxiety, depression, ecstasy, magic mushrooms, MDMA, New Approaches, psilocybin, Sigal Samuel, Vox

The new science of psychedelics

Author: Editorial 1st October 2018 0 Comments

Writing in The New Statesman , Tim Martin says: “Seventy-five years ago, in April 1943, the research chemist Albert Hofmann did something distinctly out of scientific character. Impelled by what he later called a “peculiar presentiment”, he resolved to take a second look…
Read more

a wellbeing society

addiction, Albert Hofmann, depression, isolation, LSD, MDMA, New Approaches, New Statesman, post-traumatic stress, psilocybin, psychedelic drugs, Tim Martin